Welcome to another episode of "Selling Cures," where we delve into pivotal moments in US healthcare's marketing, advertising, and public relations. Today, we're unfolding a story that shook the foundation of the healthcare industry and set a precedent for crisis management and corporate responsibility—the Tylenol poisonings of 1982. How did Johnson and Johnson navigate a nationwide crisis, restore public trust, and establish new standards for safety? We'll explore their rapid decision-making, bold actions, and transparent communication that not only reclaimed their market share but also led to crucial regulatory changes. This episode uncovers how a tragedy transformed into a case study of corporate ethics and effective crisis management. Stay tuned for this compelling story.Fun Fact: Tylenol regained its market share within a year after the crisis, thanks to Johnson and Johnson’s swift and transparent crisis management.Timestamps:00:00 Podcast on Tylenol poisonings and corporate crisis response.05:57 Tylenol crisis: tragedy, corporate accountability, safety innovation.07:04 Returning soon with another fascinating healthcare story.TopHealth - We're a media network focused exclusively on thought leadership in healthcare. Think of us of a network of podcasts, web series, newsletters, and much more!TopHealth LinkedIn - https://www.linkedin.com/company/tophealth-care/ “Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Ver todos los episodios